New Square Capital LLC Charles River Laboratories International, Inc. Transaction History
New Square Capital LLC
- $1.22 Billion
- Q1 2025
A detailed history of New Square Capital LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, New Square Capital LLC holds 63 shares of CRL stock, worth $9,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63
Previous 2
3050.0%
Holding current value
$9,550
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$926 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$771 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$650 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$363 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$296 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.71B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...